2022 - Keep eCOA Off the Critical Path of Clinical Trial Startup

In today’s patient-driven and competitive drug development landscape, healthcare organizations and related clinical studies cannot succeed without active patient insight through clinical outcome assessments (COAs). There is a growing need for the life science industry to collaborate and take a strategic approach on the patient perspective, by seamlessly incorporating COA in trials without the usual setbacks like timeline delays and increasing health authorities’ requirements. It is time to discuss how organizations can keep electronic clinical outcome assessment (eCOA) off the critical path.
In this webinar, the featured speakers will help attendees achieve study objectives and critical timelines, by providing guidance on how to optimize and carefully manage COAs from initial risk assessment to full implementation.
Discussion topics include:
Introduction to different types of COAs (different types of existing scales), general process and requirements for COA use in clinical studies
Understand the main triggers and factors that cause eCOA implementation to end up on the critical path
Understand how an end-to-end approach to eCOA implementation minimizes the risk of getting on the critical path
Join the speakers in understanding how to successfully plan and implement COA use with an end-to-end approach in clinical trial startup, from COA licensing, translation and electronic versions (eCOA).